StemPoint Capital
StemPoint Capital is a New York-based investment firm founded in 2022 by Michelle Ross, running a long-short equity strategy focused on the global life sciences industry. As of December 2023 it managed roughly $440 million in regulatory assets under management, per its SEC filings.
StemPoint Capital was founded in 2022, is headquartered in New York, United States, has 1 recorded investment, and includes 1 company in its recorded portfolio.
- Headquarters
- New York, United States
- Founded
- 2022
- AUM
- $440.0M
- Portfolio Company
- 1
- Total Investment
- 1
- Last Investment
- Jan 2022
- Geographic Focus
- Global
Indexed holds 1 portfolio company and 1 funding round for this investor. The full record is or through the API.
Investment Thesis
StemPoint Capital is a Venture Capital firm based in New York, United States. It was founded in 2022. It has made 1 investment, including Protara Therapeutics. Focus areas include Biotech.
Portfolio1
Co-investors4
Sign up to view co-investors
4 co-investors across 4 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×4 · 2 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/stempoint-capital"><img src="https://indexed.vc/api/badge/investor/stempoint-capital" alt="StemPoint Capital on Indexed.vc" width="260" height="76" /></a>